{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T20:58:32Z","timestamp":1790283512488,"version":"4.1.0"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1186\/s12933-014-0145-4","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T10:17:36Z","timestamp":1415009856000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":35,"title":["Chemerin is a novel biomarker of acute coronary syndrome but not of stable angina pectoris"],"prefix":"10.1186","volume":"13","author":[{"given":"Qingwei","family":"Ji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingzhong","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhishan","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunwu","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuyang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhe","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiutang","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chao","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujie","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,11,1]]},"reference":[{"key":"145_CR1","doi-asserted-by":"publisher","first-page":"1541","DOI":"10.1016\/j.jacc.2013.07.043","volume":"62","author":"A Ghattas","year":"2013","unstructured":"Ghattas A, Griffiths HR, Devitt A, Lip GY, Shantsila E: Monocytes in coronary artery disease and atherosclerosis where are we now?. J Am Coll Cardiol. 2013, 62: 1541-1551. 10.1016\/j.jacc.2013.07.043.","journal-title":"J Am Coll Cardiol"},{"key":"145_CR2","doi-asserted-by":"publisher","first-page":"2004","DOI":"10.1056\/NEJMra1216063","volume":"368","author":"P Libby","year":"2013","unstructured":"Libby P: Mechanisms of acute coronary syndromes and their implications for therapy. N Engl J Med. 2013, 368: 2004-2013. 10.1056\/NEJMra1216063.","journal-title":"N Engl J Med"},{"key":"145_CR3","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1161\/01.CIR.0000087480.94275.97","volume":"108","author":"M Naghavi","year":"2003","unstructured":"Naghavi M, Libby P, Falk E, Casscells SW, Litovsky S, Rumberger J, Badimon JJ, Stefanadis C, Moreno P, Pasterkamp G, Fayad Z, Stone PH, Waxman S, Raggi P, Madjid M, Zarrabi A, Burke A, Yuan C, Fitzgerald PJ, Siscovick DS, de Korte CL, Aikawa M, Juhani Airaksinen KE, Assmann G, Becker CR, Chesebro JH, Farb A, Galis ZS, Jackson C, Jang IK: From vulnerable plaque to vulnerable patient: a call for new definitions and risk assessment strategies: Part I. Circulation. 2003, 108: 1664-1672. 10.1161\/01.CIR.0000087480.94275.97.","journal-title":"Circulation"},{"key":"145_CR4","doi-asserted-by":"publisher","first-page":"915","DOI":"10.1056\/NEJM200009283431303","volume":"343","author":"JA Goldstein","year":"2000","unstructured":"Goldstein JA, Demetriou D, Grines CL, Pica M, Shoukfeh M, O\u2019Neill WW: Multiple complex coronary plaques in patients with acute myocardial infarction. N Engl J Med. 2000, 343: 915-922. 10.1056\/NEJM200009283431303.","journal-title":"N Engl J Med"},{"key":"145_CR5","doi-asserted-by":"publisher","first-page":"515","DOI":"10.1152\/physrev.00024.2005","volume":"86","author":"A Tedgui","year":"2006","unstructured":"Tedgui A, Mallat Z: Cytokines in atherosclerosis: pathogenic and regulatory pathways. Physiol Rev. 2006, 86: 515-581. 10.1152\/physrev.00024.2005.","journal-title":"Physiol Rev"},{"key":"145_CR6","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1016\/j.atherosclerosis.2012.12.029","volume":"227","author":"G Ntaios","year":"2013","unstructured":"Ntaios G, Gatselis NK, Makaritsis K, Dalekos GN: Adipokines as mediators of endothelial function and atherosclerosis. Atherosclerosis. 2013, 227: 216-221. 10.1016\/j.atherosclerosis.2012.12.029.","journal-title":"Atherosclerosis"},{"key":"145_CR7","doi-asserted-by":"publisher","first-page":"698567","DOI":"10.1155\/2013\/698567","volume":"2013","author":"SI Syed Ikmal","year":"2013","unstructured":"Syed Ikmal SI, Zaman Huri H, Vethakkan SR, Wan Ahmad WA: Potential biomarkers of insulin resistance and atherosclerosis in type 2 diabetes mellitus patients with coronary artery disease. Int J Endocrinol. 2013, 2013: 698567-10.1155\/2013\/698567.","journal-title":"Int J Endocrinol"},{"key":"145_CR8","doi-asserted-by":"publisher","first-page":"1209","DOI":"10.1007\/s00125-014-3210-3","volume":"57","author":"IW Asterholm","year":"2014","unstructured":"Asterholm IW, Rutkowski JM, Fujikawa T, Cho YR, Fukuda M, Tao C, Wang ZV, Gupta RK, Elmquist JK, Scherer PE: Elevated resistin levels induce central leptin resistance and increased atherosclerotic progression in mice. Diabetologia. 2014, 57: 1209-1218. 10.1007\/s00125-014-3210-3.","journal-title":"Diabetologia"},{"key":"145_CR9","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1007\/s12192-013-0417-z","volume":"18","author":"F Zhou","year":"2013","unstructured":"Zhou F, Pan Y, Huang Z, Jia Y, Zhao X, Chen Y, Diao J, Wan Q, Cui X: Visfatin induces cholesterol accumulation in macrophages through up-regulation of scavenger receptor-A and CD36. Cell Stress Chaperones. 2013, 18: 643-652. 10.1007\/s12192-013-0417-z.","journal-title":"Cell Stress Chaperones"},{"key":"145_CR10","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1007\/s12192-014-0499-2","volume":"19","author":"Q Wan","year":"2014","unstructured":"Wan Q, Cui X, Shao J, Zhou F, Jia Y, Sun X, Zhao X, Chen Y, Diao J, Zhang L: Beijing ambient particle exposure accelerates atherosclerosis in ApoE knockout mice by upregulating visfatin expression. Cell Stress Chaperones. 2014, 19: 715-724. 10.1007\/s12192-014-0499-2.","journal-title":"Cell Stress Chaperones"},{"key":"145_CR11","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1016\/j.coph.2003.10.011","volume":"4","author":"SE Alam","year":"2004","unstructured":"Alam SE, Nasser SS, Fernainy KE, Habib AA, Badr KF: Cytokine imbalance in acute coronary syndrome. Curr Opin Pharmacol. 2004, 4: 166-170. 10.1016\/j.coph.2003.10.011.","journal-title":"Curr Opin Pharmacol"},{"key":"145_CR12","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1111\/j.1365-2265.2008.03453.x","volume":"71","author":"SW Liu","year":"2009","unstructured":"Liu SW, Qiao SB, Yuan JS, Liu DQ: Association of plasma visfatin levels with inflammation, atherosclerosis and acute coronary syndromes (ACS) in humans. Clin Endocrinol (Oxf). 2009, 71: 202-207. 10.1111\/j.1365-2265.2008.03453.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"145_CR13","doi-asserted-by":"publisher","first-page":"405","DOI":"10.2217\/bmm.13.131","volume":"8","author":"G Basati","year":"2014","unstructured":"Basati G, Razavi AE, Abdi S, Sarrafzedegan N: Association of plasma leptin, homocysteine and nitric oxide levels with the presence and unstability of coronary artery disease. Biomark Med. 2014, 8: 405-412. 10.2217\/bmm.13.131.","journal-title":"Biomark Med"},{"key":"145_CR14","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1186\/1475-2840-12-105","volume":"12","author":"CL Huang","year":"2013","unstructured":"Huang CL, Wu YW, Wu CC, Lin L, Wu YC, Hsu PY, Jong YS, Yang WS: Association between serum adipocyte fatty-acid binding protein concentrations, left ventricular function and myocardial perfusion abnormalities in patients with coronary artery disease. Cardiovasc Diabetol. 2013, 12: 105-10.1186\/1475-2840-12-105.","journal-title":"Cardiovasc Diabetol"},{"key":"145_CR15","doi-asserted-by":"publisher","first-page":"e86404","DOI":"10.1371\/journal.pone.0086404","volume":"9","author":"CM van Stijn","year":"2014","unstructured":"van Stijn CM, Kim J, Barish GD, Tietge UJ, Tangirala RK: Adiponectin expression protects against angiotensin II-mediated inflammation and accelerated atherosclerosis. PLoS One. 2014, 9: e86404-10.1371\/journal.pone.0086404.","journal-title":"PLoS One"},{"key":"145_CR16","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1016\/j.ahj.2011.02.014","volume":"161","author":"SR Wilson","year":"2011","unstructured":"Wilson SR, Sabatine MS, Wiviott SD, Ray KK, De Lemos JA, Zhou S, Rifai N, Cannon CP, Morrow DA: Assessment of adiponectin and the risk of recurrent cardiovascular events in patients presenting with an acute coronary syndrome: observations from the Pravastatin Or atorVastatin Evaluation and Infection Trial-Thrombolysis in Myocardial Infarction 22 (PROVE IT-TIMI 22). Am Heart J. 2011, 161: 1147-1155. 10.1016\/j.ahj.2011.02.014.","journal-title":"Am Heart J"},{"key":"145_CR17","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1016\/S0828-282X(08)70602-0","volume":"24","author":"M Cheng","year":"2008","unstructured":"Cheng M, Hashmi S, Mao X, Zeng QT: Relationships of adiponectin and matrix metalloproteinase-9 to tissue inhibitor of metalloproteinase-1 ratio with coronary plaque morphology in patients with acute coronary syndrome. Can J Cardiol. 2008, 24: 385-390. 10.1016\/S0828-282X(08)70602-0.","journal-title":"Can J Cardiol"},{"key":"145_CR18","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1177\/0003319712455497","volume":"64","author":"NM Rizk","year":"2013","unstructured":"Rizk NM, El-Menyar A, Marei I, Sameer M, Musad T, Younis D, Farag F, Basem N, Al-Ali K, Al Suwaidi J: Association of adiponectin gene polymorphism (+T45G) with acute coronary syndrome and circulating adiponectin levels. Angiology. 2013, 64: 257-265. 10.1177\/0003319712455497.","journal-title":"Angiology"},{"key":"145_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.amjcard.2007.07.041","volume":"101","author":"H Otake","year":"2008","unstructured":"Otake H, Shite J, Shinke T, Watanabe S, Tanino Y, Ogasawara D, Sawada T, Hirata K, Yokoyama M: Relation between plasma adiponectin, high-sensitivity C-reactive protein, and coronary plaque components in patients with acute coronary syndrome. Am J Cardiol. 2008, 101: 1-7. 10.1016\/j.amjcard.2007.07.041.","journal-title":"Am J Cardiol"},{"key":"145_CR20","doi-asserted-by":"publisher","first-page":"854815","DOI":"10.1155\/2013\/854815","volume":"2013","author":"A Mittal","year":"2013","unstructured":"Mittal A, Gupta MD, Meennahalli Palleda G, Vyas A, Tyagi S: Relationship of plasma adiponectin levels with acute coronary syndromes and coronary lesion severity in north Indian population. ISRN Cardiol. 2013, 2013: 854815-10.1155\/2013\/854815.","journal-title":"ISRN Cardiol"},{"key":"145_CR21","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1186\/1475-2840-12-140","volume":"12","author":"JY Kim","year":"2013","unstructured":"Kim JY, Choi EY, Mun HS, Min PK, Yoon YW, Lee BK, Hong BK, Rim SJ, Kwon HM: Usefulness of metabolic syndrome score in the prediction of angiographic coronary artery disease severity according to the presence of diabetes mellitus: relation with inflammatory markers and adipokines. Cardiovasc Diabetol. 2013, 12: 140-10.1186\/1475-2840-12-140.","journal-title":"Cardiovasc Diabetol"},{"key":"145_CR22","doi-asserted-by":"publisher","first-page":"528","DOI":"10.1136\/hrt.2003.011114","volume":"90","author":"Y Nakamura","year":"2004","unstructured":"Nakamura Y, Shimada K, Fukuda D, Shimada Y, Ehara S, Hirose M, Kataoka T, Kamimori K, Shimodozono S, Kobayashi Y, Yoshiyama M, Takeuchi K, Yoshikawa J: Implications of plasma concentrations of adiponectin in patients with coronary artery disease. Heart. 2004, 90: 528-533. 10.1136\/hrt.2003.011114.","journal-title":"Heart"},{"key":"145_CR23","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1097\/MAJ.0b013e318262dbef","volume":"345","author":"H Zhang","year":"2013","unstructured":"Zhang H, Mo X, Hao Y, Huang J, Lu X, Cao J, Gu D: Adiponectin levels and risk of coronary heart disease: a meta-analysis of prospective studies. Am J Med Sci. 2013, 345: 455-461. 10.1097\/MAJ.0b013e318262dbef.","journal-title":"Am J Med Sci"},{"key":"145_CR24","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1111\/j.1365-2796.2010.02247.x","volume":"268","author":"J Persson","year":"2010","unstructured":"Persson J, Lindberg K, Gustafsson TP, Eriksson P, Paulsson-Berne G, Lundman P: Low plasma adiponectin concentration is associated with myocardial infarction in young individuals. J Intern Med. 2010, 268: 194-205. 10.1111\/j.1365-2796.2010.02247.x.","journal-title":"J Intern Med"},{"key":"145_CR25","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1093\/ije\/dyt087","volume":"42","author":"E Sook Lee","year":"2013","unstructured":"Sook Lee E, Park SS, Kim E, Sook Yoon Y, Ahn HY, Park CY, Ho Yun Y, Woo Oh S: Association between adiponectin levels and coronary heart disease and mortality: a systematic review and meta-analysis. Int J Epidemiol. 2013, 42: 1029-1039. 10.1093\/ije\/dyt087.","journal-title":"Int J Epidemiol"},{"key":"145_CR26","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/1523-1747.ep12276660","volume":"109","author":"S Nagpal","year":"1997","unstructured":"Nagpal S, Patel S, Jacobe H, DiSepio D, Ghosn C, Malhotra M, Teng M, Duvic M, Chandraratna RA: Tazarotene-induced gene 2 (TIG2), a novel retinoid-responsive gene in skin. J Invest Dermatol. 1997, 109: 91-95. 10.1111\/1523-1747.ep12276660.","journal-title":"J Invest Dermatol"},{"key":"145_CR27","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1084\/jem.20030382","volume":"198","author":"V Wittamer","year":"2003","unstructured":"Wittamer V, Franssen JD, Vulcano M, Mirjolet JF, Le Poul E, Migeotte I, Br\u00e9zillon S, Tyldesley R, Blanpain C, Detheux M, Mantovani A, Sozzani S, Vassart G, Parmentier M, Communi D: Specific recruitment of antigen-presenting cells by chemerin, a novel processed ligand from human inflammatory fluids. J Exp Med. 2003, 198: 977-985. 10.1084\/jem.20030382.","journal-title":"J Exp Med"},{"key":"145_CR28","doi-asserted-by":"publisher","first-page":"28175","DOI":"10.1074\/jbc.M700793200","volume":"282","author":"KB Goralski","year":"2007","unstructured":"Goralski KB, McCarthy TC, Hanniman EA, Zabel BA, Butcher EC, Parlee SD, Muruganandan S, Sinal CJ: Chemerin, a novel adipokine that regulates adipogenesis and adipocyte metabolism. J Biol Chem. 2007, 282: 28175-28188. 10.1074\/jbc.M700793200.","journal-title":"J Biol Chem"},{"key":"145_CR29","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1007\/s12020-012-9698-8","volume":"42","author":"AA Roman","year":"2012","unstructured":"Roman AA, Parlee SD, Sinal CJ: Chemerin: a potential endocrine link between obesity and type 2 diabetes. Endocrine. 2012, 42: 243-251. 10.1007\/s12020-012-9698-8.","journal-title":"Endocrine"},{"key":"145_CR30","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.bbrc.2012.05.103","volume":"423","author":"H Yamawaki","year":"2012","unstructured":"Yamawaki H, Kameshima S, Usui T, Okada M, Hara Y: A novel adipocytokine, chemerin exerts anti-inflammatory roles in human vascular endothelial cells. Biochem Biophys Res Commun. 2012, 423: 152-157. 10.1016\/j.bbrc.2012.05.103.","journal-title":"Biochem Biophys Res Commun"},{"key":"145_CR31","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s12020-011-9550-6","volume":"41","author":"Q Yan","year":"2012","unstructured":"Yan Q, Zhang Y, Hong J, Gu W, Dai M, Shi J, Zhai Y, Wang W, Li X, Ning G: The association of serum chemerin level with risk of coronary artery disease in Chinese adults. Endocrine. 2012, 41: 281-288. 10.1007\/s12020-011-9550-6.","journal-title":"Endocrine"},{"key":"145_CR32","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1097\/MCA.0b013e3283576a60","volume":"23","author":"L Xiaotao","year":"2012","unstructured":"Xiaotao L, Xiaoxia Z, Yue X, Liye W: Serum chemerin levels are associated with the presence and extent of coronary artery disease. Coron Artery Dis. 2012, 23: 412-416. 10.1097\/MCA.0b013e3283576a60.","journal-title":"Coron Artery Dis"},{"key":"145_CR33","first-page":"539","volume":"58","author":"X Lin","year":"2012","unstructured":"Lin X, Tang X, Jiang Q, Liu Q, Lin Z, Lin J, Chen L, Hong H: Elevated serum chemerin levels are associated with the presence of coronary artery disease in patients with type 2 diabetes. Clin Lab. 2012, 58: 539-544.","journal-title":"Clin Lab"},{"key":"145_CR34","doi-asserted-by":"publisher","first-page":"256","DOI":"10.1016\/j.atherosclerosis.2014.05.912","volume":"235","author":"M Herov\u00e1","year":"2014","unstructured":"Herov\u00e1 M, Schmid M, Gemperle C, Loretz C, Hersberger M: Low dose aspirin is associated with plasma chemerin levels and may reduce adipose tissue inflammation. Atherosclerosis. 2014, 235: 256-262. 10.1016\/j.atherosclerosis.2014.05.912.","journal-title":"Atherosclerosis"},{"key":"145_CR35","doi-asserted-by":"publisher","first-page":"606","DOI":"10.1016\/S0002-9149(83)80105-2","volume":"51","author":"GG Gensini","year":"1983","unstructured":"Gensini GG: A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983, 51: 606-10.1016\/S0002-9149(83)80105-2.","journal-title":"Am J Cardiol"},{"key":"145_CR36","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1186\/1475-2840-11-84","volume":"11","author":"HM Kim","year":"2012","unstructured":"Kim HM, Lee BW, Song YM, Kim WJ, Chang HJ, Choi DH, Yu HT, Kang E, Cha BS, Lee HC: Potential association between coronary artery disease and the inflammatory biomarker YKL-40 in asymptomatic patients with type 2 diabetes mellitus. Cardiovasc Diabetol. 2012, 11: 84-10.1186\/1475-2840-11-84.","journal-title":"Cardiovasc Diabetol"},{"key":"145_CR37","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.atherosclerosis.2012.12.012","volume":"226","author":"Y Okamoto","year":"2013","unstructured":"Okamoto Y, Ishii S, Croce K, Katsumata H, Fukushima M, Kihara S, Libby P, Minami S: Adiponectin inhibits macrophage tissue factor, a key trigger of thrombosis in disrupted atherosclerotic plaques. Atherosclerosis. 2013, 226: 373-377. 10.1016\/j.atherosclerosis.2012.12.012.","journal-title":"Atherosclerosis"},{"key":"145_CR38","doi-asserted-by":"publisher","first-page":"162","DOI":"10.3109\/07853890.2012.727020","volume":"45","author":"M Venoj\u00e4rvi","year":"2013","unstructured":"Venoj\u00e4rvi M, Wasenius N, Manderoos S, Heinonen OJ, Hernelahti M, Lindholm H, Surakka J, Lindstr\u00f6m J, Aunola S, Atalay M, Eriksson JG: Nordic walking decreased circulating chemerin and leptin concentrations in middle-aged men with impaired glucose regulation. Ann Med. 2013, 45: 162-170. 10.3109\/07853890.2012.727020.","journal-title":"Ann Med"},{"key":"145_CR39","doi-asserted-by":"publisher","first-page":"698","DOI":"10.12659\/MSM.890784","volume":"20","author":"M Meric","year":"2014","unstructured":"Meric M, Soylu K, Avci B, Yuksel S, Gulel O, Yenercag M, Coksevim M, Uzun A: Evaluation of plasma chemerin levels in patients with non-dipper blood pressure patterns. Med Sci Monit. 2014, 20: 698-705. 10.12659\/MSM.890784.","journal-title":"Med Sci Monit"},{"key":"145_CR40","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1111\/j.1365-2265.2009.03664.x","volume":"72","author":"J Weigert","year":"2010","unstructured":"Weigert J, Neumeier M, Wanninger J, Filarsky M, Bauer S, Wiest R, Farkas S, Scherer MN, Sch\u00e4ffler A, Aslanidis C, Sch\u00f6lmerich J, Buechler C: Systemic chemerin is related to inflammation rather than obesity in type 2 diabetes. Clin Endocrinol (Oxf). 2010, 72: 342-348. 10.1111\/j.1365-2265.2009.03664.x.","journal-title":"Clin Endocrinol (Oxf)"},{"key":"145_CR41","doi-asserted-by":"publisher","first-page":"26","DOI":"10.1016\/j.ejps.2013.08.031","volume":"1","author":"G Derosa","year":"2014","unstructured":"Derosa G, Cicero AF, Carbone A, Querci F, Fogari E, D\u2019Angelo A, Maffioli P: Results from a 12\u2009months, randomized, clinical trial comparing an olmesartan\/amlodipine single pill combination to olmesartan and amlodipine monotherapies on blood pressure and inflammation. Eur J Pharm Sci. 2014, 1: 26-33. 10.1016\/j.ejps.2013.08.031.","journal-title":"Eur J Pharm Sci"},{"key":"145_CR42","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/j.metabol.2013.06.004","volume":"62","author":"J Van de Voorde","year":"2013","unstructured":"Van de Voorde J, Pauwels B, Boydens C, Decaluw\u00e9 K: Adipocytokines in relation to cardiovascular disease. Metabolism. 2013, 62: 1513-1521. 10.1016\/j.metabol.2013.06.004.","journal-title":"Metabolism"},{"key":"145_CR43","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1016\/j.jjcc.2013.11.006","volume":"63","author":"K Nakamura","year":"2014","unstructured":"Nakamura K, Fuster JJ, Walsh K: Adipokines: a link between obesity and cardiovascular disease. J Cardiol. 2014, 63: 250-259. 10.1016\/j.jjcc.2013.11.006.","journal-title":"J Cardiol"},{"key":"145_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1186\/1475-2840-10-87","volume":"10","author":"X Gao","year":"2011","unstructured":"Gao X, Mi S, Zhang F, Gong F, Lai Y, Gao F, Zhang X, Wang L, Tao H: Association of chemerin mRNA expression in human epicardial adipose tissue with coronary atherosclerosis. Cardiovasc Diabetol. 2011, 10: 87-10.1186\/1475-2840-10-87.","journal-title":"Cardiovasc Diabetol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s12933-014-0145-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-014-0145-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-014-0145-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-014-0145-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T06:24:35Z","timestamp":1630563875000},"score":1,"resource":{"primary":{"URL":"https:\/\/cardiab.biomedcentral.com\/articles\/10.1186\/s12933-014-0145-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["145"],"URL":"https:\/\/doi.org\/10.1186\/s12933-014-0145-4","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,11,1]]},"assertion":[{"value":"4 October 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 October 2014","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 November 2014","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"145"}}